PQ 264
264. Deputy Peter Burke asked the Minister for Health if Ireland can now reassess its position with regard to supplying Ampligen for patients suffering from myalgic encephalomyelitis, ME, due to the distribution of Ampligen by countries in Europe (details supplied) under the early access programme; and if he will make a statement on the matter. [5111/17]
Introduced
2 February 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
2 February 2017
Summary
264. Deputy Peter Burke asked the Minister for Health if Ireland can now reassess its position with regard to supplying Ampligen for patients suffering from myalgic encephalomyelitis, ME, due to the distribution of Ampligen by countries in Europe (details supplied) under the early access programme; and if he will make a statement on the matter. [5111/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Licensing
Medicinal Products Licensing
xml · EN · 2 February 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-02-02/264/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-02-02/pq_264